Senior insider sale
Chief Financial Officer at OPUS GENETICS, INC. — senior position signals high conviction
$206.3K
49.78K shares
What this filing means
GAGNON ROBERT E. plans to sell 49.78K shares of OPUS GENETICS, INC. valued at approximately $206.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/23/2026ACC: 0001974158-26-000110
Officer· Chief Financial Officer
Since Sep 2025
49.78K
Shares to sell
$206.3K
Approx. market value
14K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vested Restricted Stock Units
N/A
1/22/2026
14KTotal acquired14K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/22/2026 | Vested Restricted Stock Units N/A | 14K | — |
| Total | 14K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
28K
Market value
$127.2K
9/3/2026
—Completed
Units to sell
7.78K
Market value
$22.9K
7/23/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
14K
Market value
$56.1K
10/23/2026
Total
Units
49.78K
Value
$206.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/3/2026 | 28K | $127.2K | — | Completed |
7/23/2026 | 7.78K | $22.9K | — | Completed |
| Planned — Approximate Date | ||||
10/23/2026 | 14K | $56.1K | Nasdaq | Planned |
| Total | 49.78K | $206.3K | ||